Looking through charts, CVAC caught my eye for some potential trade opportunities.
Firstly lets look at the candle close of Today 08/01/23
-> We are currently testing this RED Resistance Arrow Line pointing down
-> The candle has a lower wick, indicating some buying pressure
->However, the candle body is small, which may indicate waning momentum
**If price...
Welcome to the BasicTrading channel.
My name is Philip and in todays analysis I quickly go over the situation which we currently have on UnitedHealth Group.
I will analyse the asset both from a weekly and daily timeframe to show you the best possible trading opportunities.
If you enjoyed this analysis, let me know in the comment section which asset I should...
At the start of 2022, healthcare stocks have gotten killed, especially anything that was a winner in the past 1-2 years. A lot of people are getting rather bearish, but they shouldn't be. The fundamentals favor healthcare still in many ways, and momentum is still rather strong. We already got the breakout in healthcare stocks, and we just got the retest, which was...
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan®
today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational Device Exemption (IDE) application, permitting Check-Cap to begin a pivotal study of C-Scan in the U.S.
The pivotal study will evaluate safety and performance of C-Scan as well as subject...
Tangible catalyst behind surge is due to the upcoming launch of Truforma , Zomedica’s point-of-care (POC) diagnostic device for the detection of thyroid disease in dogs and cats and adrenal disease in dogs.
The platform will hit the market on March 30 , and ahead of the product’s debut, the company has also just nabbed a vital distribution deal.
Last week,...
